NORTHVALE, N.J., Sept. 29, 2008 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (AMEX:ELI) in collaboration with ThePharmaNetwork, LLC., announced today the acceptance by the U.S.

CHICAGO and CARLSBAD, Calif., June 2 /PRNewswire-FirstCall/ -- Isis Pharmaceuticals, Inc. announced today that two of the Company's partnered oncology drugs were highlighted during the American Society of Clinical Oncology (ASCO) meeting.

NORTHVALE, N.J., April 29, 2008 (PRIME NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (AMEX:ELI), announced the appointment of Stuart Apfel M.D., its current Chief Medical Officer as its Chief Scientific Officer. Dr. Apfel will replace Dr.

NORTHVALE, N.J., March 3, 2008 (PRIME NEWSWIRE) -- Elite Pharmaceuticals, Inc.

Elite Pharmaceuticals, Inc. (AMEX: ELI), a leading